A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
15581067
PII: file/5974/fb2004a0023.pdf
Knihovny.cz E-zdroje
- MeSH
- běloši genetika MeSH
- diabetes mellitus 2. typu etnologie genetika MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci * MeSH
- glycin genetika MeSH
- lidé MeSH
- polymorfismus genetický * MeSH
- rizikové faktory MeSH
- serin genetika MeSH
- studie případů a kontrol MeSH
- transkripční faktory genetika MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Slovinsko MeSH
- Názvy látek
- glycin MeSH
- peroxisome-proliferator-activated receptor-gamma coactivator-1 MeSH Prohlížeč
- serin MeSH
- transkripční faktory MeSH
The PGC-1 gene has been implicated in the regulation of several genes controlling energy metabolism. The prevalent Gly482Ser polymorphism of the PGC-1 gene has been shown to be associated with type 2 diabetes in some but not all studies. The aim of this study was to analyse whether the Gly482Ser variant is a risk factor for development of type 2 diabetes in Slovene population (Caucasians). Genotyping of the Gly482Ser polymorphism was performed for 545 subjects: 305 patients with type 2 diabetes and 240 non-diabetic controls. The Gly482Ser genotype distribution in patients with type 2 diabetes (AA = 11.5%, AG = 42.3%, GG = 46.2%) differed from genotype distribution in non-diabetic controls (AA = 6.3%, AG = 46.3%, GG = 47.5%), and the AA genotype was associated with 1.9-times increased risk of type 2 diabetes (95% confidence interval 1.0-3.6; P = 0.036). In conclusion, we suggest that the AA genotype of the Gly482Ser polymorphism of the PGC-1 gene should be considered as a risk factor for the development of type 2 diabetes in Caucasians.